Genomics Advocate von Eschenbach Confirmed as FDA Commissioner

Dec 08, 2006

NEW YORK (GenomeWeb News) — The US Senate yesterday confirmed Andrew von Eschenbach to be the new commissioner off the Food and Drug Administration.

The Bush appointee, a staunch supporter of genomic technologies in drug discovery, was approved after serving as acting commissioner since September 2005 after former commissioner Lester Crawford resigned.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Spiders and Scorpions, Oh My!

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

Keep It Secret

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Page Joins Chronic Disease Startup

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

This Week in Cell

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.

Main menu